These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3486809)

  • 1. [Rejection mechanisms of allografts. Role of regional lymph nodes in the development of cytotoxic T lymphocytes].
    Mori K
    Fukuoka Igaku Zasshi; 1986 Feb; 77(2):87-97. PubMed ID: 3486809
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
    Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
    Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo mechanisms of alloreactivity. V. Influence of graft implantation on the activation and redistribution of graft-reactive CTL.
    Orosz CG; Horstemeyer B; Zinn NE; Bishop DK; Ferguson RM
    Transplantation; 1989 Sep; 48(3):519-23. PubMed ID: 2675412
    [No Abstract]   [Full Text] [Related]  

  • 4. Rejection mechanism of class I disparate heart allografts in a rat model.
    Stepkowski SM; Ito T
    Transplant Proc; 1989 Apr; 21(2):3303-6. PubMed ID: 2652820
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalization and lymphocyte traffic after allograft challenge.
    Clemmings SM; Hoffman RA; Cahill DR; Simmons RL; Ascher NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):359-60. PubMed ID: 3274786
    [No Abstract]   [Full Text] [Related]  

  • 8. The tolerance that develops in recipients of cultured allografts is an active process that affects both the activation and effector function of cytotoxic T cells.
    Talmage DW; La Rosa FG; Smilek D; Ammons TJ
    Prog Clin Biol Res; 1986; 224():187-94. PubMed ID: 3491996
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional graft-versus-host and host-versus-graft reactions: histology of the popliteal lymph nodes.
    Korcáková L; Holub M; Hasková V
    Folia Biol (Praha); 1974; 20(5):309-13. PubMed ID: 4155380
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymph node removal enhances corneal graft survival in mice at high risk of rejection.
    Plsková J; Holán V; Filipec M; Forrester JV
    BMC Ophthalmol; 2004 Mar; 4():3. PubMed ID: 15038832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recirculation of cytolytic T cells from a single lymph node during an immune response to allogeneic leukocytes.
    Verhagen AM; Kimpton WG; Nash AD
    Transplantation; 1995 Feb; 59(3):432-5. PubMed ID: 7871577
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte recruitment properties of regional lymph node or spleen cells during skin allograft rejection.
    Hanto DW; Harty JT; Simmons RL
    Transplantation; 1983 Nov; 36(5):578-81. PubMed ID: 6356522
    [No Abstract]   [Full Text] [Related]  

  • 15. Different mechanisms of rejection of organ and cell allografts.
    Olszewski WL; Jasklowska-Englisz M; Lukomska B
    Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional lymph node activation in mice by a soluble product released during contact of normal allogeneic lymph node cells.
    Korcáková L; Hasková V
    Transplantation; 1974 Oct; 18(4):347-9. PubMed ID: 4422916
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
    Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
    J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of the lymph node and splenic lymphocytes of mice in inactivation of allogeneic hematopoietic stem cells].
    Dozmorov IM; Lutsenko GV; Nikolaeva IS; Petrov RV; Rudneva TB
    Biull Eksp Biol Med; 1985 May; 99(5):592-4. PubMed ID: 3890981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.